Skip to main content

Table 4 Comparisons of USP2a expression and clinopathological features of bladder cancer

From: Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis

Variable

Patient (%)

mRNA expression of USP2a (median with IQR; × 10^3 copies/μl)

p value

Grade

  

0.666

 G1

56 (18.4)

186.4 (68.7–345.0)

 

 G2

132 (43.3)

151.4 (47.3–463.2)

 

 G3

117 (38.4)

137.3 (40.4–502.4)

 

NMIBC

  

0.681

 Ta

48 (26.1)

160.3 (68.7–340.2)

 

 T1

136 (73.9)

184.7 (65.4–489.5)

 

MIBC

  

0.024

 T2 or T3, N0, M0

67 (55.4)

136.7 (41.6–567.2)

 

 T4 or N ≥1 or M1

54 (44.6)

71.7 (15.8–296.1)

 
  1. IQR interquartile range; NMIBC non muscle invasive bladder cancer; MIBC muscle invasive bladder cancer